The Largest Law Enforcement Agency in the State of Kansas, Johnson County Sherriff’s Office, to Become First in the Nation to Deploy AditxtScore™ for Immune Scoring for its Employees and First Responders

AditxtScore™ will be used for Assessing Immune Status for COVID-19

RICHMOND, Va.--(BUSINESS WIRE)--Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company that improves the health of the immune system, announced today that the Johnson County Sherriff’s Office, the largest law enforcement agency in the State of Kansas with over 700 employees, will become the first agency in the Nation to deploy AditxtScore™ for assessing the immune status for COVID-19 in its employees.

AditxtScore™ is an immune monitoring platform which provides a personalized and comprehensive profile of the immune system. AditxtScore™ for COVID-19 helps to answer the growing need for a personalized approach to combating the pandemic. AditxtScore™ further differentiates itself by quantitatively measuring the strength of an individual’s immune response to the novel coronavirus with high precision, helping patients and their providers make informed decisions for a proper course of action.

Sheriff Calvin Hayden commented, “If an individual’s antibodies are low, they may decide to get the vaccine or a booster. Alternatively, if their antibodies are high, either due to natural infection or from the vaccine, it may be best for them to wait on the booster. With their AditxtScore™, they will finally have the information to guide these important health decisions – information they do not currently have. Informed individuals are empowered to make healthy decisions.” He added, “The Johnson County Sheriff's Office has done a stellar job of managing COVID-19. We haven’t skipped a beat in the services we’ve provided, and the AditxtScore™ immune profile takes it to the next level.”

“AditxtScore™ provides meaningful information to help understand one’s personal immune response to COVID-19 and not just that of the population collectively,” said Amro Albanna, Co-founder and Chief Executive Officer of Aditxt. Aditxt’s immune monitoring platform is a pioneering approach to the health of our immune system. “Precision immunotherapies can only be effectively developed when we have a better understanding of the immune system. This understanding is the guiding principle of AditxtScore™,” Amro added. “AditxtScore™ for COVID-19 application provides an opportunity to assess the immunity status in response to COVID-19 by measuring levels of multiple antibody isotypes (IgM, IgG and IgA) that can develop against components of the spike protein encoded by current vaccines, as well as additional viral proteins that can be produce in response to natural infection. Additionally, measurement of the neutralizing capabilities of these antibodies further illustrates the effectiveness of the immune response to help protect against future infections.”

Dave Owen, President of KanVest Services, an Aditxt channel partner and advisor to the Johnson County Sherriff’s Office, commented, “AditxtScore™ provides a unique, precise, and comprehensive test that delivers so much more than simply a ‘negative’ or ‘positive’ test result, as with standard antibody tests. Just as not all people are alike in how their bodies respond to the virus and/or the vaccine, not all antibody tests are alike. How are individuals to know if they have a ‘high protective level of antibodies’ or ‘low at-risk level of antibodies’ or ‘no antibodies’ given the fact that most tests on the market simply indicate ‘yes, you have some antibodies’, or ‘no, you do not have antibodies’. We are proud to be a channel partner of Aditxt and distribute the AditxtScore™ for COVID-19. It equips individuals with their personal immune profile so they can make informed decisions about their health. The AditxtScore™ immune monitoring tool is an essential component for the public and private sectors, managing through the COVID-19 pandemic.”

About Aditxt™

Aditxt develops technologies focused on improving the health of the immune system through immune monitoring and reprogramming. Aditxt’s immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. Aditxt’s immune reprogramming technology, currently in the preclinical state, is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. AditxtScore™ for COVID-19 is Aditxt’s proprietary immune profile technology to equip people with information about their personal level of protection. For more information, please visit: www.aditxt.com www.AditxtScore™.com

About KanVest Services

KanVest Services is a healthtech company that provides products and services that support preventive health, for the public and private sectors across the US. KanVest is a national distributor of AditxtScore™ for COVID-19, a comprehensive immune profile that measures the strength of an individual’s immune response to COVID-19, so they can make informed decisions with the optimal course of action for their health, to better navigate the global pandemic. …getting America back to normal with confidence– using science. www.Kanvest.com

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of federal securities laws. Forward looking statements include statements regarding the Company’s intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Company’s ongoing and planned product and business development; the Company’s intellectual property position; the Company’s ability to develop commercial functions; expectations regarding product launch and revenue; the Company’s results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more fully discussed in the section titled “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company’s other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.